Toggle navigation
Home
Search
Services
Blog
Contact
About
Oral Antisense Therapy for Cancer
Manoharan, Muthiah
Isis Pharmaceuticals, Inc., Carlsbad, CA, United States
Search 8 grants from Muthiah Manoharan
Search grants from Isis Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Elucidating a Role for Blastema-Enriched Genes in Salamander Limb Regeneration,
Neural Correlates of Infant Attention and Action
Chromatin Structure In Regulation Of Mammalian Gene Expression
Mechanisms of Selectin Shedding in Leukocyte Recruitment
Novel Automated Tumor Detection Method
Recently added grants:
Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients
Isolation and Assessment of Blood-Circulating Cancer Exosomes with LSS and SERS Lab on a Chip Optical Spectroscopic Instrument
Multiparametric MRI-guided Prostate HDR Brachytherapy with Focal Tumor Boost
Extracellular vesicle RNA signaling in liver tumor microenvironment
Molecular Genetics of Lyme Arthritis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41CA083543-01
Application #
6020093
Study Section
Special Emphasis Panel (ZRG1-SSS-1 (02))
Program Officer
Fu, Yali
Project Start
2000-07-01
Project End
2002-06-30
Budget Start
2000-07-01
Budget End
2002-06-30
Support Year
1
Fiscal Year
2000
Total Cost
$123,990
Indirect Cost
Institution
Name
Isis Pharmaceuticals, Inc.
Department
Type
DUNS #
361949092
City
Carlsbad
State
CA
Country
United States
Zip Code
92010
Comments
Be the first to comment on Muthiah Manoharan's grant